VANGUARD GROUP INC - MATINAS BIOPHARMA HLDGS INC ownership

MATINAS BIOPHARMA HLDGS INC's ticker is MTNB and the CUSIP is 576810105. A total of 72 filers reported holding MATINAS BIOPHARMA HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of MATINAS BIOPHARMA HLDGS INC
ValueSharesWeighting
Q3 2023$1,137,996
-63.8%
8,753,818
+0.4%
0.00%
Q2 2023$3,139,350
-23.8%
8,720,418
-0.5%
0.00%
Q1 2023$4,117,275
-4.3%
8,760,160
+1.8%
0.00%
Q4 2022$4,303,261
-19.7%
8,606,521
+2.1%
0.00%
Q3 2022$5,362,000
-19.3%
8,430,174
+0.2%
0.00%
Q2 2022$6,647,000
+4.8%
8,414,074
+6.7%
0.00%
Q1 2022$6,343,000
-20.8%
7,884,919
-0.6%
0.00%
Q4 2021$8,012,000
-21.8%
7,932,515
+0.7%
0.00%
Q3 2021$10,246,000
+68.0%
7,881,101
+0.1%
0.00%
Q2 2021$6,100,000
-26.0%
7,872,463
+0.3%
0.00%
Q1 2021$8,244,000
-21.3%
7,851,850
+2.0%
0.00%
Q4 2020$10,470,000
+79.3%
7,698,642
+1.0%
0.00%
Q3 2020$5,838,000
-0.9%
7,621,1300.0%0.00%
Q2 2020$5,892,000
+29.6%
7,621,130
+0.6%
0.00%
Q1 2020$4,545,000
-62.3%
7,574,530
+42.7%
0.00%
Q4 2019$12,051,000
+268.9%
5,308,807
+2.4%
0.00%
Q3 2019$3,267,000
-23.7%
5,181,896
+3.7%
0.00%
Q2 2019$4,282,000
+9.8%
4,997,918
+39.7%
0.00%
Q1 2019$3,901,000
+137.4%
3,578,800
+29.6%
0.00%
Q4 2018$1,643,000
-29.5%
2,761,783
+9.0%
0.00%
Q3 2018$2,331,000
+110.8%
2,533,333
-0.6%
0.00%
Q2 2018$1,106,000
-48.1%
2,549,409
-8.4%
0.00%
Q1 2018$2,129,000
-32.0%
2,784,159
+3.1%
0.00%
Q4 2017$3,131,000
-10.0%
2,699,548
+2.4%
0.00%
Q3 2017$3,479,000
-15.9%
2,635,632
+7.7%
0.00%
Q2 2017$4,135,0002,446,9770.00%
Other shareholders
MATINAS BIOPHARMA HLDGS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 1,429,532$1,944,0000.61%
Boxer Capital, LLC 11,478,634$15,611,0000.50%
Vivo Capital, LLC 6,451,612$8,774,0000.39%
Philadelphia Financial Management of San Francisco, LLC 740,861$1,008,0000.26%
DCF Advisers, LLC 305,299$415,0000.17%
Main Street Financial Solutions, LLC 400,826$545,0000.11%
Platform Technology Partners 158,660$216,0000.10%
STALEY CAPITAL ADVISERS INC 600,000$816,0000.05%
MONECO Advisors, LLC 50,000$81,0000.04%
CCG WEALTH MANAGEMENT, LLC 30,000$41,0000.04%
View complete list of MATINAS BIOPHARMA HLDGS INC shareholders